BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24380554)

  • 1. Free circulating DNA as a biomarker of colorectal cancer.
    Cassinotti E; Boni L; Segato S; Rausei S; Marzorati A; Rovera F; Dionigi G; David G; Mangano A; Sambucci D; Dionigi R
    Int J Surg; 2013; 11 Suppl 1():S54-7. PubMed ID: 24380554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free circulating DNA as possible tumour marker in colorectal cancer.
    Boni L; Cassinotti E; Canziani M; Dionigi G; Rovera F; Dionigi R
    Surg Oncol; 2007 Dec; 16 Suppl 1():S29-31. PubMed ID: 18024018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of mutant free circulating tumor DNA in the plasma of patients with gastrointestinal stromal tumor harboring activating mutations of CKIT or PDGFRA.
    Maier J; Lange T; Kerle I; Specht K; Bruegel M; Wickenhauser C; Jost P; Niederwieser D; Peschel C; Duyster J; von Bubnoff N
    Clin Cancer Res; 2013 Sep; 19(17):4854-67. PubMed ID: 23833305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of plasma DNA in colorectal cancer patients: a novel prognostic tool.
    Frattini M; Gallino G; Signoroni S; Balestra D; Battaglia L; Sozzi G; Leo E; Pilotti S; Pierotti MA
    Ann N Y Acad Sci; 2006 Sep; 1075():185-90. PubMed ID: 17108210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of K-ras mutations in plasma after colorectal tumor resection.
    Lindforss U; Zetterquist H; Papadogiannakis N; Olivecrona H
    Anticancer Res; 2005; 25(1B):657-61. PubMed ID: 15816642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic implications of serum microRNA-21 in colorectal cancer.
    Menéndez P; Padilla D; Villarejo P; Palomino T; Nieto P; Menéndez JM; Rodríguez-Montes JA
    J Surg Oncol; 2013 Nov; 108(6):369-73. PubMed ID: 23970420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The concentration of deoxyribonucleic acid in plasma from 73 patients with colorectal cancer and apparent clinical correlations.
    Guadalajara H; Domínguez-Berzosa C; García-Arranz M; Herreros MD; Pascual I; Sanz-Baro R; García-Olmo DC; García-Olmo D
    Cancer Detect Prev; 2008; 32(1):39-44. PubMed ID: 18400415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating cell-free DNA in serum as a biomarker of colorectal cancer.
    da Silva Filho BF; Gurgel AP; Neto MÁ; de Azevedo DA; de Freitas AC; Silva Neto Jda C; Silva LA
    J Clin Pathol; 2013 Sep; 66(9):775-8. PubMed ID: 23833048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel serum nucleosomics biomarkers for the detection of colorectal cancer.
    Holdenrieder S; Dharuman Y; Standop J; Trimpop N; Herzog M; Hettwer K; Simon K; Uhlig S; Micallef J
    Anticancer Res; 2014 May; 34(5):2357-62. PubMed ID: 24778043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of putative circulating cancer stem cells in patients undergoing hepatic resection for colorectal liver metastasis.
    Pilati P; Mocellin S; Bertazza L; Galdi F; Briarava M; Mammano E; Tessari E; Zavagno G; Nitti D
    Ann Surg Oncol; 2012 Feb; 19(2):402-8. PubMed ID: 22071867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and monitoring of cell-free DNA in blood of patients with colorectal cancer.
    Schwarzenbach H; Stoehlmacher J; Pantel K; Goekkurt E
    Ann N Y Acad Sci; 2008 Aug; 1137():190-6. PubMed ID: 18837946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early detection of recurrence after curative resection for colorectal cancer - obstacles when using soluble biomarkers?
    Nielsen HJ; Jess P; Aldulaymi BH; Jørgensen LN; Laurberg S; Nielsen KT; Madsen MR; Brünner N; Christensen IJ
    Scand J Gastroenterol; 2013 Mar; 48(3):326-33. PubMed ID: 23324066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic identification and validation of candidate genes for detection of circulating tumor cells in peripheral blood specimens of colorectal cancer patients.
    Findeisen P; Röckel M; Nees M; Röder C; Kienle P; Von Knebel Doeberitz M; Kalthoff H; Neumaier M
    Int J Oncol; 2008 Nov; 33(5):1001-10. PubMed ID: 18949363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer.
    Oh T; Kim N; Moon Y; Kim MS; Hoehn BD; Park CH; Kim TS; Kim NK; Chung HC; An S
    J Mol Diagn; 2013 Jul; 15(4):498-507. PubMed ID: 23747112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating transforming growth factor beta 1 as a predictor of liver metastasis after resection in colorectal cancer.
    Tsushima H; Ito N; Tamura S; Matsuda Y; Inada M; Yabuuchi I; Imai Y; Nagashima R; Misawa H; Takeda H; Matsuzawa Y; Kawata S
    Clin Cancer Res; 2001 May; 7(5):1258-62. PubMed ID: 11350892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular detection of circulating cancer cells in the peripheral blood of patients with colorectal cancer by using membrane array with a multiple mRNA marker panel.
    Yeh CS; Wang JY; Wu CH; Chong IW; Chung FY; Wang YH; Yu YP; Lin SR
    Int J Oncol; 2006 Feb; 28(2):411-20. PubMed ID: 16391796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free DNA and carcinoembryonic antigen serum levels: an important combination for diagnosis of colorectal cancer.
    Flamini E; Mercatali L; Nanni O; Calistri D; Nunziatini R; Zoli W; Rosetti P; Gardini N; Lattuneddu A; Verdecchia GM; Amadori D
    Clin Cancer Res; 2006 Dec; 12(23):6985-8. PubMed ID: 17145818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
    Griesenberg D; Nürnberg R; Bahlo M; Klapdor R
    Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.